secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001683168-23-002522
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma amends bylaws to set quorum at one-third of outstanding shares
--------------------------------------------------------------------------------

- Quorum for shareholder meetings now one-third of outstanding common voting stock.
- Amendment adopted on April 17, 2023; no other bylaw changes disclosed.
- Fiscal year unchanged; no impact on capital structure or business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/0001683168-23-002522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-002522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer